Telix Other Stockholder Equity vs Total Assets Analysis

TLX Stock   17.13  0.09  0.53%   
Telix Pharmaceuticals financial indicator trend analysis is much more than just breaking down Telix Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telix Pharmaceuticals is a good investment. Please check the relationship between Telix Pharmaceuticals Other Stockholder Equity and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Other Stockholder Equity vs Total Assets

Other Stockholder Equity vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telix Pharmaceuticals Other Stockholder Equity account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Telix Pharmaceuticals' Other Stockholder Equity and Total Assets is 0.51. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Assets in the same time period over historical financial statements of Telix Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Telix Pharmaceuticals' Other Stockholder Equity and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Telix Pharmaceuticals Limited are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Other Stockholder Equity i.e., Telix Pharmaceuticals' Other Stockholder Equity and Total Assets go up and down completely randomly.

Correlation Coefficient

0.51
Relationship DirectionPositive 
Relationship StrengthWeak

Other Stockholder Equity

Total Assets

Total assets refers to the total amount of Telix Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Telix Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Telix Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Selling General Administrative is likely to rise to about 95.4 M in 2025, despite the fact that Tax Provision is likely to grow to (2.3 M).
 2022 2023 2024 2025 (projected)
Interest Expense6.4M13.1M15.1M15.9M
Depreciation And Amortization228.5K6.7M6.1M6.4M

Telix Pharmaceuticals fundamental ratios Correlations

0.930.910.980.990.98-0.920.980.980.990.980.920.920.950.950.970.510.991.0-0.280.990.97-0.9-0.420.990.97
0.930.950.970.910.97-0.780.960.880.920.880.750.740.810.980.980.270.930.93-0.080.90.93-0.79-0.390.950.94
0.910.950.950.910.94-0.70.940.820.930.820.690.710.760.970.970.280.90.89-0.140.860.84-0.7-0.310.930.95
0.980.970.950.951.0-0.840.990.930.980.930.840.840.890.991.00.410.980.97-0.210.960.96-0.87-0.390.990.99
0.990.910.910.950.96-0.920.950.980.980.980.890.890.910.930.960.470.960.99-0.270.960.93-0.85-0.40.970.93
0.980.970.941.00.96-0.860.990.940.980.940.860.850.90.990.990.420.980.98-0.240.970.97-0.88-0.390.990.98
-0.92-0.78-0.7-0.84-0.92-0.86-0.85-0.98-0.89-0.98-0.95-0.93-0.94-0.78-0.83-0.6-0.91-0.940.37-0.94-0.910.930.46-0.88-0.81
0.980.960.940.990.950.99-0.850.930.990.930.870.870.920.980.980.460.990.97-0.20.970.96-0.89-0.431.00.99
0.980.880.820.930.980.94-0.980.930.951.00.950.940.960.880.920.530.960.99-0.320.980.96-0.92-0.450.950.9
0.990.920.930.980.980.98-0.890.990.950.950.90.910.940.950.970.510.990.98-0.270.980.95-0.88-0.40.990.98
0.980.880.820.930.980.94-0.980.931.00.950.950.940.960.880.920.530.960.99-0.320.980.96-0.92-0.450.950.9
0.920.750.690.840.890.86-0.950.870.950.90.950.990.990.770.810.640.930.93-0.390.950.91-0.95-0.530.890.85
0.920.740.710.840.890.85-0.930.870.940.910.940.990.990.770.820.610.920.92-0.430.950.89-0.94-0.510.880.85
0.950.810.760.890.910.9-0.940.920.960.940.960.990.990.840.870.610.960.95-0.380.980.94-0.96-0.50.930.9
0.950.980.970.990.930.99-0.780.980.880.950.880.770.770.840.990.370.950.94-0.170.930.94-0.82-0.330.980.98
0.970.980.971.00.960.99-0.830.980.920.970.920.810.820.870.990.360.970.96-0.230.950.95-0.83-0.350.990.98
0.510.270.280.410.470.42-0.60.460.530.510.530.640.610.610.370.360.520.51-0.220.540.47-0.63-0.240.470.44
0.990.930.90.980.960.98-0.910.990.960.990.960.930.920.960.950.970.520.99-0.30.990.98-0.93-0.410.990.98
1.00.930.890.970.990.98-0.940.970.990.980.990.930.920.950.940.960.510.99-0.280.990.98-0.92-0.440.990.95
-0.28-0.08-0.14-0.21-0.27-0.240.37-0.2-0.32-0.27-0.32-0.39-0.43-0.38-0.17-0.23-0.22-0.3-0.28-0.31-0.280.33-0.17-0.24-0.23
0.990.90.860.960.960.97-0.940.970.980.980.980.950.950.980.930.950.540.990.99-0.310.98-0.95-0.450.980.95
0.970.930.840.960.930.97-0.910.960.960.950.960.910.890.940.940.950.470.980.98-0.280.98-0.94-0.410.980.95
-0.9-0.79-0.7-0.87-0.85-0.880.93-0.89-0.92-0.88-0.92-0.95-0.94-0.96-0.82-0.83-0.63-0.93-0.920.33-0.95-0.940.53-0.9-0.87
-0.42-0.39-0.31-0.39-0.4-0.390.46-0.43-0.45-0.4-0.45-0.53-0.51-0.5-0.33-0.35-0.24-0.41-0.44-0.17-0.45-0.410.53-0.42-0.39
0.990.950.930.990.970.99-0.881.00.950.990.950.890.880.930.980.990.470.990.99-0.240.980.98-0.9-0.420.99
0.970.940.950.990.930.98-0.810.990.90.980.90.850.850.90.980.980.440.980.95-0.230.950.95-0.87-0.390.99
Click cells to compare fundamentals

Telix Pharmaceuticals Account Relationship Matchups

Telix Pharmaceuticals fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets157.8M109.8M255.4M398.3M458.0M480.9M
Short Long Term Debt Total2.2M2.5M10.4M17.4M20.1M21.1M
Other Current Liab6.3M6.1M4.9M123.0M141.5M148.5M
Total Current Liabilities20.0M38.0M85.6M157.4M181.0M190.1M
Total Stockholder Equity79.0M2.2M80.0M148.9M171.2M179.8M
Property Plant And Equipment Net4.8M6.3M18.8M30.5M35.1M36.8M
Net Debt(75.7M)(19.5M)(105.9M)(105.8M)(95.2M)(90.5M)
Accounts Payable5.8M11.9M16.8M32.8M37.8M39.7M
Cash77.9M22.0M116.3M123.2M141.7M148.8M
Non Current Assets Total64.2M62.3M82.1M173.5M199.5M209.4M
Cash And Short Term Investments77.9M22.0M116.3M123.2M141.7M148.8M
Good Will4.2M4.1M5.5M4.8M5.6M5.9M
Common Stock Shares Outstanding280.4M285.1M316.3M323.7M372.3M390.9M
Liabilities And Stockholders Equity157.8M109.8M255.4M398.3M458.0M480.9M
Non Current Liabilities Total58.8M69.7M89.8M92.0M105.8M111.1M
Inventory633K3.5M8.5M17.3M19.9M20.9M
Other Current Assets2.7M2.6M9.1M19.5M22.5M23.6M
Total Liab78.8M107.7M175.3M249.4M286.8M301.1M
Total Current Assets93.6M47.5M173.2M224.8M258.6M271.5M
Accumulated Other Comprehensive Income4.9M4.8M(18.2M)(33.7M)(30.3M)(28.8M)
Short Term Debt767K632K641K1.6M1.4M1.3M
Common Stock167.1M170.8M371.0M446.3M513.2M538.9M
Current Deferred Revenue174.6K7.1M19.3M63.2M72.6M76.3M
Retained Earnings(93.0M)(173.5M)(272.8M)(263.7M)(237.3M)(225.4M)
Non Currrent Assets Other183K212K327K586K527.4K501.0K
Net Receivables12.4M19.4M39.4M64.8M74.5M78.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.